Clinical Trial Update: Adequacy of Perioperative Cefuroxime Dosage According to the BMI [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating adequacy of perioperative cefuroxime dosage adjusted for BMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• cefuroxime (cefuroxime)

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Obesity; Drug | Phase 4 | Status: COMPLETED